Friday, 22 February 2019
Latest news
Main » Boston Scientific Corp (NYSE:BSX) 2017 Q2 Sentiment

Boston Scientific Corp (NYSE:BSX) 2017 Q2 Sentiment

12 October 2017

It is down 19.12% since October 11, 2016 and is uptrending. It has underperformed by 28.46% the S&P500. Days to cover increased from 3.0 to 4.0 and the percentage of shorted shares is 0.01% as of September 29. The company's institutional ownership is monitored at 32.9 percent. The company has market cap of $5.06 billion. It closed at $29.34 lastly. Bright Horizons Family Solutions Inc (BFAM) has risen 18.19% since October 10, 2016 and is uptrending. BlackRock Inc. now owns 100,184,511 shares of the medical equipment provider's stock worth $2,777,113,000 after buying an additional 4,439,966 shares during the period. Its up 0.14, from 0.89 in 2017Q1. Sold All: 41 Reduced: 173 Increased: 165 New Position: 56. Public Employees Retirement System Of Ohio holds 991,450 shares or 0.15% of its portfolio. Deltec Asset Lc holds 1.51% or 266,000 shares. Boston Scientific Corporation is given 10 buy-equivalent recommendations, 0 sells and 6 holds. 35,985 were accumulated by Oppenheimer Asset Mgmt. Creative Planning holds 0.01% or 42,540 shares. Comerica Bancorporation holds 694,808 shares. Dorsey Whitney Ltd Liability accumulated 0.05% or 8,318 shares. The authority will not be accountable for anyone who makes stock portfolio or financial decisions as per this reporting, which has been constructed only on limited and open source information. This is assuming the current $0.31 EPS is accurate. Rmb Ltd Co has 120,258 shares. Peddock Advsr Ltd Liability Corp reported 0.11% of its portfolio in Boston Scientific Corporation (NYSE:BSX). Crestwood Advisors Llc acquired 11,147 shares as Boston Scientific Corp Com (BSX)'s stock rose 4.02%.

07/27/2017 - Boston Scientific Corporation had its "outperform" rating reiterated by analysts at Cowen. They see Boston Scientific Corporation (BSX) price hitting a mean target of $31.02 a share, meaning the stock still has potential that could lift the price another 5.73% Also, the recent close suggests the stock is underpriced by 15.88% compared to the most bullish target. Therefore 78% are positive. Of the analysts surveyed by Reuters that track Boston Scientific Corporation 6 of them rate its stock a hold. Geode Capital Management LLC now owns 12,120,374 shares of the medical equipment provider's stock worth $300,963,000 after buying an additional 888,331 shares during the period. The company was maintained on Tuesday, June 27 by Jefferies. The rating was maintained by RBC Capital Markets with "Buy" on Tuesday, May 30.

Indicating how profitable Boston Scientific Corporation (NYSE:BSX) is relative to its assets, the ROA value is displayed at 4.40%. Wedbush maintained Boston Scientific Corporation (NYSE:BSX) rating on Friday, July 29. The stock has "Buy" rating by Needham on Friday, April 28. On Friday, July 29 the stock rating was maintained by JP Morgan with "Overweight". RBC Capital Markets maintained Boston Scientific Corporation (NYSE:BSX) rating on Monday, October 2. It has outperformed by 1.49% the S&P500. On average, equities analysts anticipate that Boston Scientific Corporation will post $1.26 earnings per share for the current year.

Wall Street await Boston Scientific Corporation (NYSE:BSX) to release earnings on October, 25. They now have a Dollars 31 price target on the stock.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the business.

Sabra Healthcare REIT, Inc. - 7 (NASDAQ:SBRAP) Trading Volume Significantly Lower
Creative Planning accumulated 16,417 shares. (NASDAQ:MNTA) has "Sell" rating given on Wednesday, September 7 by Maxim Group. Gilman Hill Asset Management Llc increased Sabra Health Care Reit Inc (SBRA) stake by 14.01% reported in 2017Q2 SEC filing.

More important recent ViaSat, Inc. The company realized a fall in short interest of -3.57% between September 15, 2017 and September 29, 2017. More interesting news about ViaSat, Inc. The shares were sold at an average price of $26.67, for a total transaction of $266,700.00.

Investors sentiment decreased to 1.84 in 2017 Q2. Guardian Life Insurance Co. of America boosted its position in Boston Scientific Corporation by 0.9% in the 1st quarter. It turned negative, as 24 investors sold VSAT shares while 37 reduced holdings. 44,507 are owned by Legal And General Group Inc Plc. Korea Inv holds 2.02 million shares. Pure Finance Advsrs Incorporated stated it has 0.1% of its portfolio in ViaSat, Inc. (NASDAQ:VSAT). Millennium Mgmt Limited Liability has 0.25% invested in ViaSat, Inc.

Since May 1, 2017, it had 0 buys, and 7 insider sales for $2.58 million activity. The correct version of this news story can be viewed at The New York-based Bluemountain Cap Mngmt Lc has invested 0.01% in ViaSat, Inc. At one point in the past year, the shares traded as low as $19.67 but has recovered 49.16% since then. Wafra Investment Advisory Group Inc holds 449,386 shares or 0.63% of its portfolio. Ahl Llp stated it has 99,959 shares.

Receive Boston Scientific Corporation News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Boston Scientific Corporation with's FREE daily email newsletter.